Langston, Amelia A.
61  Ergebnisse:
?
 
?
6

A randomised, placebo-controlled phase 3 study to evaluate ..:

Ljungman, Per ; Bermudez, Arancha ; Logan, Aaron, C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2021.100787.  , 2021
 
?
7

Allogeneic hematopoietic cell transplantation with non-myel..:

Cooper, Jason P ; Storer, Barry E ; Granot, Noa...
Cooper , J P , Storer , B E , Granot , N , Gyurkocza , B , Sorror , M L , Chauncey , T R , Shizuru , J , Franke , G N , Maris , M B , Boyer , M , Bruno , B , Sahebi , F , Langston , A A , Hari , P , Agura , E D , Petersen , S L , Maziarz , R T , Bethge , W , Asch , J , Gutman , J A , Olesen , G , Yeager , A M , Hübel , K , Hogan , W J , Maloney , D G , Mielcarek , M , Martin , P J , Flowers , M E D , Georges , G E , Woolfrey , A E , Joachim Deeg , H , Scott , B L , McDonald , G B , Storb , R & Sandmaier , B M 2021 , ' Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies : Improved outcomes over two decades ' , Haematologica , vol. 106 , no. 6 , pp. 1599-1607 . https://doi.org/10.3324/haematol.2020.248187.  , 2021
 
?
10

A randomised, placebo-controlled phase 3 study to evaluate ..:

Ljungman, Per ; Bermudez, Arancha ; Logan, Aaron, C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2021.100787.  , 2021
 
?
 
?
15

A randomised, placebo-controlled phase 3 study to evaluate ..:

Ljungman, Per ; Bermudez, Arancha ; Logan, Aaron, C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2021.100787.  , 2021
 
1-15